−0.84USD
−36.95 MUSD
37.61 M
About Larimar Therapeutics, Inc.
Sector
Industry
CEO
Carole S. Ben-Maimon
Website
Headquarters
Bala Cynwyd
Employees (FY)
42
Founded
2005
FIGI
BBG001J2NVH0
Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of LRMR is 6.40 USD — it has decreased by 1.99% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Larimar Therapeutics, Inc. stocks are traded under the ticker LRMR.
Larimar Therapeutics, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
LRMR stock is 5.98% volatile and has beta coefficient of 1.29. Check out the list of the most volatile stocks — is Larimar Therapeutics, Inc. there?
LRMR earnings for the last quarter are −0.21 USD per share, whereas the estimation was −0.22 USD resulting in a 6.02% surprise. The estimated earnings for the next quarter are −0.25 USD per share. See more details about Larimar Therapeutics, Inc. earnings.
Yes, you can track Larimar Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
LRMR stock has fallen by 8.05% compared to the previous week, the month change is a 25.23% fall, over the last year Larimar Therapeutics, Inc. has showed a 33.33% increase.
LRMR net income for the last quarter is −12.99 M USD, while the quarter before that showed −9.06 M USD of net income which accounts for −43.35% change. Track more Larimar Therapeutics, Inc. financial stats to get the full picture.
Today Larimar Therapeutics, Inc. has the market capitalization of 408.32 M, it has decreased by 5.91% over the last week.
No, LRMR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, LRMR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Larimar Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 42.00 employees. See our rating of the largest employees — is Larimar Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Larimar Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Larimar Therapeutics, Inc. stock shows the neutral signal. See more of Larimar Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Larimar Therapeutics, Inc. future price: according to them, LRMR price has a max estimate of 27.00 USD and a min estimate of 10.00 USD. Read a more detailed Larimar Therapeutics, Inc. forecast: see what analysts think of Larimar Therapeutics, Inc. and suggest that you do with its stocks.